Multi-gene anoikis signature combined with tumor microenvironment stratifies prognosis in cutaneous melanoma with experimental validation of PTK6
Gene · 2025
DOI: 10.1016/j.gene.2025.149686 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gene, 2025. Verfasst von Jiaqiong Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510280, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Melanoma, Anoikis, Skin Neoplasms. Die Arbeit nennt 44 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Cutaneous melanoma (CM) exhibits aggressive behavior driven by anoikis resistance and dysregulated tumor microenvironment (TME). The combined prognostic value of anoikis susceptibility and immune landscape remains uncharacterized. METHODS: Using transcriptomic data from 471 TCGA-CM patients, we developed an 11-gene anoikis risk score (RS) through LASSO-Cox regression, with external validation in the GSE65904 cohort (n = 214). This risk score was integrated with ESTIMATE-quantified immune/stromal features to construct the RS-TME classifier. Functional validation focused on Protein Tyrosine Kinase 6 (PTK6), a key prognostic driver, employing in vitro and in vivo models. RESULTS: We established an 11-gene RS with superior predictive capacity compared to conventional clinical indicators. Consensus clustering identified two molecular subtypes where Cluster B showed significantly improved survival compared to Cluster A (p < 0.001). Single-cell RNA sequencing confirmed immune cells, particularly macrophages, possessed substantially higher anoikis scores than malignant cells. This microenvironment foundation guided development of the RS-TME classifier, which stratified patients into three prognostic groups. Low-risk/high-TME patients exhibited significantly superior survival outcomes (p < 0.001), with external validation in the GSE65904 cohort (p = 0.002). Crucially, PTK6 knockdown suppressed tumor progression through increased apoptosis, reduced cell viability, impaired migration, and decreased tumor volume, mediated by Hippo pathway activation. CONCLUSIONS: The RS-TME classifier is the first model integrating anoikis resistance and immune microenvironment to predict survival and immunotherapy response. Simultaneously, PTK6 targeting suppresses CM progression via Hippo-mediated anoikis resistance, providing a foundation for personalized treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510280, China.
- Yunkang School of Medicine and Health, Nanfang College, Guangzhou,518000, China.
- Department of Dermatology, Panyu Hospital of Chinese Medicine, Guangzhou, China. Electronic address: 248237854@qq.com.
- General Surgery Department, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital of Guangzhou Medica…
Zitieren
APA
Lin, J., Lin, Y., Jian, X., & Li, X. (2025). Multi-gene anoikis signature combined with tumor microenvironment stratifies prognosis in cutaneous melanoma with experimental validation of PTK6. Gene. https://doi.org/10.1016/j.gene.2025.149686
Vancouver
Lin J, Lin Y, Jian X, Li X. Multi-gene anoikis signature combined with tumor microenvironment stratifies prognosis in cutaneous melanoma with experimental validation of PTK6. Gene. 2025. doi:10.1016/j.gene.2025.149686
BibTeX
@article{Lin2025,
author = {Lin, Jiaqiong and Lin, Yan and Jian, Xueyi and Li, Xiaoyong},
title = {Multi-gene anoikis signature combined with tumor microenvironment stratifies prognosis in cutaneous melanoma with experimental validation of PTK6},
journal = {Gene},
year = {2025},
doi = {10.1016/j.gene.2025.149686}
}
EUVIMED